Bipolar Disorder Women with Regular Cycles Report Higher Premenstrual Symptom Burden in Norwegian Survey

The study, presented at the 2026 ECNP Congress but not yet peer-reviewed, relied on self-reported menstrual patterns and retrospective symptom recall over the prior year. Regular-cycle participants were also less likely to use hormonal contraception, with higher rates of discontinuation due to perceived side effects. This pattern aligns with prior observational data linking cycle regularity to mood sensitivity in affective disorders.

Existing literature, including a 2022 Lancet Psychiatry review on reproductive psychiatry, shows that up to 70% of women with bipolar disorder experience premenstrual exacerbation, yet guidelines from NICE and APA offer minimal direction on cycle-timed interventions. The current findings highlight an overlooked gap: women avoiding contraception may forgo a potential stabilizer while also missing gynecological screening.

The survey design cannot establish causality or rule out recall bias and selection effects from online recruitment. A longitudinal cohort with prospective daily ratings and hormone assays is required to test whether cycle regularity predicts treatment response or whether tailored progestin regimens reduce episode frequency.

Future work should examine interactions with mood stabilizers such as lithium or valproate, which themselves alter menstrual patterns, to clarify whether observed differences reflect biology or treatment choices.